DPP4 and bullous pemphigoid: Two weeks prior to referral, he developed widespread blisters, initially suspected to represent dipeptidyl peptidase-4 (DPP-4) inhibitor–associated bullous pemphigoid (BP), given the well-established link between DPP-4 inhibitors and autoimmune blistering disorders at that time.